Manufacturing, Drug Products

May 09, 2023

According to a press release, SGS has doubled its capacity for nitrosamine testing for North American customers.

March 06, 2023

The guidance is intended to build on the existing International Council for Harmonisation (ICH) quality guidance.

April 03, 2022

Collaboration and new tools aid efforts to implement new processing technologies for small-molecule drug product manufacturing.

January 03, 2022

A new focus on speed to market creates challenges for facility design and construction.

November 11, 2021

Hovione will invest $170 million in new capacity and capabilities in Portugal, Ireland, and New Jersey

September 22, 2021

Lonza’s investment in its Stein and Basel facilities in Switzerland aims to expand its overall drug product development and manufacturing services.

September 16, 2021

The COVID-19 pandemic has further impacted ongoing drug shortage issues; essential action is needed to avoid repeating previous mistakes.

August 31, 2021

USAntibiotics will serve as the sole American-based provider of amoxicillin and amoxil clavulanate.

August 18, 2021

The Cleveland, Ohio facility will produce critical anti-infective drug products for US hospitals.

August 17, 2021

Syngene’s additions include a new microbial facility and an expanded mammalian facility.